Source: TradingView.com.Key TakeawaysPfizer shares have gained ground since a report over the weekend said that activist investor Starboard Value has taken a roughly $1 billion stake in the drug maker and is pushing for changes.The stock has formed a cup and handle, a chart pattern signaling a potential bullish reversal.Investors should watch higher price levels on Pfizer's chart around $31.75, $34.75, $37, and $39.75, while also monitoring the $28.25 support area. Pfizer (PFE) shares have gained ground s ...

My last article on Pfizer (NYSE: PFE )(NEOE: PFE:CA ) was bullish and published back in February, 2024. I am even more bullish now because the stock seems to have found a bottom. I am also bullish because it appears thatLong-time stock market investor focused on strategic buying opportunities with dividend and value stocks. This investment strategy has resulted in a near 5 star rating on Tipranks.com and over 9,000 followers on Seeking Alpha. Follow me on Twitter for my latest trading ideas: @Hawkinvest1Ana ...

Starboard Value has taken a $1 billion stake in drugmaker Pfizer.The hedge fund, headed by Jeff Smith, has become one of the most feared activist investors.Starboard has doubled its assets over the past decade targeting companies across industries. Sign up to get the inside scoop on today’s biggest stories in markets, tech, and business — delivered daily. Read preview Thanks for signing up! Go to newsletter preferences Thanks for signing up! Access your favorite topics in a personalized feed while ...

Pfizer (PFE, Financial) stock saw a notable increase of 2.94% attributed to a reported $1 billion investment by activist investor Starboard Value. This strategic move is intended to breathe new life into Pfizer, as the stock has experienced a substantial decrease from its highs during the pandemic era.The pharmaceutical giant Pfizer (PFE, Financial) faces hurdles, notably a sharp decline in the demand for its COVID-19 vaccines as the pandemic eases. Moreover, the company has been unable to keep pace with co ...

Can Starboard Value and former CEO Ian Read save Pfizer stock?Pfizer (PFE 2.89%) stock jumped 3.1% through 11:20 a.m. ET Monday morning in response to a Wall Street Journal article over the weekend, reporting on a $1 billion investment in the company by activist investor Starboard Value. With Pfizer stock down 50% from the record-high prices its shares commanded during the height of the pandemic, Starboard is offering to help Pfizer turn its business around.How Pfizer got itself in a pickleAs the Journal ex ...

Media reports indicate that activist investor Starboard Value has acquired approximately $1 billion worth of shares in Pfizer (PFE, Financial). Following this news, Pfizer's stock rose nearly 3% in pre-market trading. Starboard Value is reportedly in discussions with Pfizer's former CEO, Ian Read, and former CFO, Frank D’Amelio, to assist in enhancing the company's performance.The hedge fund has expressed concerns that Pfizer's current CEO, Albert Bourla, who succeeded Read in 2019, lacks the acquisition di ...

Pfizer TodayPFEPfizer$29.40 +0.82 (+2.87%) 52-Week Range$25.20▼$33.92Dividend Yield5.71%Price Target$34.54Add to WatchlistPfizer Inc. NYSE: PFE hit its peak during the COVID-19 pandemic when its vaccines developed with BioNTech SE NASDAQ: BNTX sent shares surging up to $61.71 in December 2021, driven by its COVID-19 vaccine sales. Since then, it's been downhill for the medical sector giant as COVID revenues dried up with the pandemic in the rearview mirror. Normalization set in, and investors jumped out. Pf ...

Pfizer Inc. PFE may have been a hero in the COVID-19 vaccine race, but its stock is stuck in the slow lane. Down nearly 14% over the last year, the pharma giant's shares have struggled as demand for its pandemic-related treatments has fizzled out.But things could get interesting—activist investor Starboard Value just acquired a $1 billion stake in the company.Could this signal a turning point for the pharma giant?Starboard To The Rescue?Starboard Value, led by Jeff Smith, isn't shy about shaking things up. ...

KEY TAKEAWAYSStarboard Value reportedly has taken a roughly $1 billion stake in Pfizer, as the activist investor seeks to turn the struggling drugmaker around. According to The Wall Street Journal, Starboard has approached Ian Read, a former Pfizer chief executive, and ex-finance chief Frank D’Amelio to help aid its efforts.Pfizer shares are rising about 3% in premarket trading but have almost halved since their pandemic peak in 2021, as demand for its COVID-19 vaccines slumped. Shares of Pfizer (PFE) are r ...

Activist investor Starboard Value has taken a $1 billion stake in beleaguered drugmaker Pfizer Inc. and is seeking a turnaround, the Wall Street Journal reported late Sunday.Citing unnamed sources familiar with the matter, the Journal reported Starboard has approached two former Pfizer executives to assist in its efforts, though Starboard’s specific plans were not revealed. ...